share_log

Summit Therapeutics Says Accepted Offers From Multiple Investors To Purchase Aggregate Of 10.35M Shares At $22.70 Per Share For Aggregate Gross Proceeds Of $235M

Summit Therapeutics Says Accepted Offers From Multiple Investors To Purchase Aggregate Of 10.35M Shares At $22.70 Per Share For Aggregate Gross Proceeds Of $235M

summit therapeutics表示已接受多家投资者购买总计1035万股股票,每股价格为22.70美元,总交易金额为2.35亿美元。
Benzinga ·  09/12 03:36

All of Summit's Section 16 officers participated in the capital raise. A total of $79 million was raised by insiders, including Robert W. Duggan, Dr. Maky Zanganeh, Manmeet S. Soni, and Bhaskar Anand, as well as Jeff Huber, a member of the Board of Directors, who invested via a controlled entity. The remaining $156 million was raised with multiple leading biopharma institutional investors.

所有Summit的第16条款的高级管理人员参与了资本筹集活动。内部人士筹集了总共$79,000,000,包括Robert W. Duggan、Dr. Maky Zanganeh、Manmeet S. Soni和Bhaskar Anand,以及董事会成员Jeff Huber通过受控实体进行投资。其余的$156,000,000由多家主要生物制药机构投资者筹集。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发